B. 1. Benjamin, A. Pierce, and R. Cunin, L'essentiel de la génétique, édition De Boeck, 2012.

C. Hutter, L. Mechanic, N. Chatterjee, P. Kraft, E. Gillanders et al., Gene-Environment Interactions in Cancer Epidemiology: A National Cancer Institute Think Tank Report, Genetic Epidemiology, vol.27, issue.15, pp.643-657, 2013.
DOI : 10.1002/gepi.21756

I. Coupier and P. Pujol, [Hereditary predispositions to gynaecological cancers

D. Stoppa-lyonnet, M. Stern, N. Soufir, and G. Lenoir, Pr??dispositions g??n??tiques aux cancers??: actualit??s et perspectives en 2010, Pathologie Biologie, vol.58, issue.5, pp.324-330, 2010.
DOI : 10.1016/j.patbio.2010.02.004

A. Chompret, Clinical and molecular diagnosis of inherited breast-ovarian cancer], J Gynécologie Obstétrique Biol Reprod. avr, vol.32, issue.2, pp.101-119, 2003.

R. Wooster, S. Neuhausen, J. Mangion, Y. Quirk, D. Ford et al., Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13, Science, vol.265, issue.5181, pp.2088-2090, 1994.
DOI : 10.1126/science.8091231

M. Stratton, D. Ford, S. Neuhasen, S. Seal, R. Wooster et al., Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q, Nature Genetics, vol.1, issue.1, pp.103-107, 1994.
DOI : 10.1038/ng1093-109

Y. Miki, J. Swensen, D. Shattuck-eidens, P. Futreal, K. Harshman et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182
DOI : 10.1126/science.7545954

P. Welcsh and M. King, BRCA1 and BRCA2 and the genetics of breast and ovarian [Identification and management of hereditary breast-ovarian cancers, 2004.

N. Kauff, S. Domchek, T. Friebel, M. Robson, J. Lee et al., Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study, Journal of Clinical Oncology, vol.26, issue.8, pp.1331-1337, 2008.
DOI : 10.1200/JCO.2007.13.9626

A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord et al., Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1130, 2003.
DOI : 10.1086/375033

N. Mavaddat, S. Peock, D. Frost, S. Ellis, R. Platte et al., Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI Journal of the National Cancer Institute, vol.105, issue.11, pp.812-822, 2013.
DOI : 10.1093/jnci/djt095

K. Metcalfe, S. Gershman, H. Lynch, P. Ghadirian, N. Tung et al., Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer, vol.351, issue.9, pp.1384-1392, 2011.
DOI : 10.1038/bjc.2011.120

S. Domchek, K. Jhaveri, S. Patil, J. Stopfer, C. Hudis et al., Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer

J. Varley, G. Mcgown, M. Thorncroft, M. Santibanez-koref, A. Kelsey et al., Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families, Cancer Res. 1 août, vol.57, issue.15, pp.3245-3252, 1997.

S. Gibbon, J. Galen, J. Mozersky, A. Zur-nieden, and S. Palfner, Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA, édition Routledge, 2014.

N. Turner, A. Tutt, and A. Ashworth, Opinion: Hallmarks of 'BRCAness' in sporadic cancers, Nature Reviews Cancer, vol.56, issue.10, pp.814-819, 2004.
DOI : 10.1093/jnci/90.15.1138

J. Iqbal, A. Ragone, J. Lubinski, H. Lynch, P. Moller et al., The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer, vol.54, issue.12, pp.2005-2009, 2012.
DOI : 10.1200/JCO.2011.39.5590

M. Beiner, A. Finch, B. Rosen, J. Lubinski, P. Moller et al., The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study, Gynecologic Oncology, vol.104, issue.1, pp.7-10, 2007.
DOI : 10.1016/j.ygyno.2006.08.004

T. Kirchhoff, N. Kauff, N. Mitra, K. Nafa, H. Huang et al., BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews, Clinical Cancer Research, vol.10, issue.9, pp.2918-2921, 2004.
DOI : 10.1158/1078-0432.CCR-03-0604

D. Easton, S. Narod, D. Ford, and M. Steel, The genetic epidemiology of BRCA1, The Lancet, vol.344, issue.8924, p.761, 1994.
DOI : 10.1016/S0140-6736(94)92256-X

G. Chêne, F. Penault-llorca, I. Raoelfils, Y. Bignon, I. Ray-coquard et al., Ovarian carcinogenesis: recent and past hypotheses]. Gynécologie Obstétrique Fertil, avr, vol.39, issue.4, pp.216-223, 2011.

. Disponible-sur, has-sante.fr/portail/jcms/c_1050648/fr/depistage-du- cancer-du-sein-en-france-identification-des-femmes-a-haut-risque-et-modalites-de- depistage-note-de-cadrage?xtmc=&xtcr=9

F. Eisinger, N. Alby, A. Bremond, J. Dauplat, M. Espié et al., Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee, Annals of Oncology, vol.9, issue.9, pp.939-950, 1998.
DOI : 10.1023/A:1008389021382

. Inca, principales-recommandations-de-prise-en-charge-des-femmes-porteuses- dune-mutation-de-brca1-ou-brca2, Cancer Res BCR, vol.6, issue.1, pp.8-17, 2004.

P. Osin and S. Lakhani, The pathology of familial breast cancer: Immunohistochemistry and molecular analysis, Breast Cancer Research, vol.34, issue.1, pp.36-40, 1999.
DOI : 10.1046/j.1365-2559.1999.00548.x

S. Lakhani, S. Manek, F. Penault-llorca, A. Flanagan, L. Arnout et al., Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers, Clinical Cancer Research, vol.10, issue.7, pp.2473-2481, 2004.
DOI : 10.1158/1078-0432.CCR-1029-3

K. Bolton, G. Chenevix-trench, C. Goh, S. Sadetzki, S. Ramus et al., Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer, JAMA, vol.307, issue.4, pp.382-390, 2012.
DOI : 10.1001/jama.2012.20

J. Lecarpentier, C. Noguès, E. Mouret-fourme, D. Stoppa-lyonnet, C. Lasset et al., Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, the French National BRCA1/2 carrier cohort (GENEPSO)
URL : https://hal.archives-ouvertes.fr/hal-00698006

T. Rebbeck, T. Friebel, T. Wagner, H. Lynch, J. Garber et al., Mutation Carriers: The PROSE Study Group, Journal of Clinical Oncology, vol.23, issue.31, pp.7804-7810, 2005.
DOI : 10.1200/JCO.2004.00.8151

A. Antoniou, M. Rookus, N. Andrieu, R. Brohet, J. Chang-claude et al., Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1

J. Chang-claude, N. Andrieu, M. Rookus, R. Brohet, A. Antoniou et al., Age at menarche and menopause and breast cancer risk in the International BRCA1

C. Carrier and . Study, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, avr, vol.16, issue.4, pp.740-746, 2007.

A. Valentini, J. Lubinski, T. Byrski, P. Ghadirian, P. Moller et al., The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation, Breast Cancer Research and Treatment, vol.38, issue.1, pp.177-185, 2013.
DOI : 10.1007/s10549-013-2729-1

C. Nestle-krämling and T. Kühn, Role of Breast Surgery in BRCA Mutation Carriers, Breast Care, vol.7, issue.5, pp.378-382, 2012.
DOI : 10.1159/000343717

C. Garcia-etienne, M. Barile, O. Gentilini, E. Botteri, N. Rotmensz et al., Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer?, Annals of Surgical Oncology, vol.286, issue.18, pp.3380-3387, 2009.
DOI : 10.1245/s10434-009-0638-7

B. Haffty, E. Harrold, A. Khan, P. Pathare, T. Smith et al., Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status, The Lancet, vol.359, issue.9316, pp.1471-1477, 2002.
DOI : 10.1016/S0140-6736(02)08434-9

M. Van-der-sangen, F. Van-de-wiel, P. Poortmans, V. Tjan-heijnen, G. Nieuwenhuijzen et al., Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ???40??years, Breast Cancer Research and Treatment, vol.353, issue.16, pp.207-215, 2011.
DOI : 10.1007/s10549-010-1110-x

A. Valachis, A. Nearchou, and P. Lind, Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis, Breast Cancer Research and Treatment, vol.101, issue.15 suppl, pp.443-455, 2014.
DOI : 10.1007/s10549-014-2890-1

E. Imyanitov and V. Moiseyenko, Drug therapy for hereditary cancers, Hereditary Cancer in Clinical Practice, vol.19, issue.Suppl 1, p.5, 2011.
DOI : 10.1111/IGC.0b013e3181bb703f

W. Foulkes, J. Goffin, J. Brunet, L. Bégin, N. Wong et al., Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status, JNCI Journal of the National Cancer Institute, vol.94, issue.19, pp.1504-1506, 2002.
DOI : 10.1093/jnci/94.19.1504-a

L. Huiart, A. Bouhnik, D. Rey, C. Tarpin, C. Cluze et al., Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?, European Journal of Cancer, vol.48, issue.13, pp.1939-1946, 1990.
DOI : 10.1016/j.ejca.2012.03.004

C. Cluze, D. Rey, L. Huiart, M. Bendiane, A. Bouhnik et al., Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time, Annals of Oncology, vol.23, issue.4, pp.882-890, 2012.
DOI : 10.1093/annonc/mdr330

J. Cuzick, A. Decensi, B. Arun, P. Brown, M. Castiglione et al., Preventive therapy for breast cancer: a consensus statement, The Lancet Oncology, vol.12, issue.5, pp.496-503, 2011.
DOI : 10.1016/S1470-2045(11)70030-4

P. Fong, D. Boss, T. Yap, A. Tutt, P. Wu et al., Mutation Carriers, New England Journal of Medicine, vol.361, issue.2, pp.123-134, 2009.
DOI : 10.1056/NEJMoa0900212

J. Prat, A. Ribé, and A. Gallardo, Hereditary ovarian cancer, Human Pathology, vol.36, issue.8, pp.861-870, 2005.
DOI : 10.1016/j.humpath.2005.06.006

A. Tutt, M. Robson, J. Garber, S. Domchek, M. Audeh et al., Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial, The Lancet, vol.376, issue.9737, pp.235-244, 2010.
DOI : 10.1016/S0140-6736(10)60892-6

. Inca, recommandations-de-pratique-clinique/586-chirurgie-prophylactique-dans-les- cancers-avec-predisposition-genetique

K. Singh, J. Lester, B. Karlan, C. Bresee, T. Geva et al., Impact of family history on BRCA2 carriers, Microsurgery. mai, vol.34, issue.4, pp.271-276, 2014.

A. Finch, K. Metcalfe, J. Chiang, L. Elit, J. Mclaughlin et al., The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation, Psycho-Oncology, vol.39, issue.2, pp.212-219, 2013.
DOI : 10.1002/pon.2041

A. Finch, K. Metcalfe, J. Chiang, L. Elit, J. Mclaughlin et al., The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation, Gynecologic Oncology, vol.121, issue.1, pp.163-168, 2011.
DOI : 10.1016/j.ygyno.2010.12.326

M. Pike, R. Ross, R. Lobo, T. Key, M. Potts et al., LHRH agonists and the prevention of breast and ovarian cancer, British Journal of Cancer, vol.60, issue.1, pp.142-148, 1989.
DOI : 10.1038/bjc.1989.237

P. Lasset, C. Berthet, P. Dugast, C. Delaloge, and S. , Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial, On behalf the French Federation of Cancer Centres Pujol, pp.77-84, 2012.

E. Warner, D. Plewes, K. Hill, P. Causer, J. Zubovits et al., Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination, JAMA, vol.292, issue.11, pp.1317-1325, 2004.
DOI : 10.1001/jama.292.11.1317

S. Schrading and C. Kuhl, Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer, Radiology, vol.246, issue.1, pp.58-70, 2008.
DOI : 10.1148/radiol.2461062173

A. Berrington-de-gonzalez, C. Berg, K. Visvanathan, and M. Robson, Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.101, issue.3, pp.205-209, 2009.
DOI : 10.1093/jnci/djn440

H. Autorité-de-santé-ald, 30 -Cancer du sein Disponible sur, 2010.

H. Autorité-de-santé-ald, 30 -Cancer de l'ovaire [Internet] Disponible sur, 2010.

F. Eisinger, Genetic testing for familial cancer. The French National Report (year 2003), Community Genet, vol.11, issue.1, pp.63-67, 2008.

J. Mancini, C. Noguès, C. Adenis, P. Berthet, V. Bonadona et al., Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing, European Journal of Cancer, vol.42, issue.7, pp.871-881, 1990.
DOI : 10.1016/j.ejca.2005.10.029

URL : https://hal.archives-ouvertes.fr/hal-00428000

F. Eisinger, It???s not for me??? It???s for my daughter, European Journal of Cancer, vol.43, issue.2, pp.226-227, 1990.
DOI : 10.1016/j.ejca.2006.08.027

I. Van-oostrom, H. Meijers-heijboer, H. Duivenvoorden, A. Bröcker-vriends, C. Van-asperen et al., Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress, Patient Education and Counseling, vol.65, issue.1
DOI : 10.1016/j.pec.2006.05.006

I. Van-oostrom, H. Meijers-heijboer, H. Duivenvoorden, A. Bröcker-vriends, C. Van-asperen et al., Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study, Clinical Genetics, vol.13, issue.2, pp.35-42, 2007.
DOI : 10.1111/j.1399-0004.2007.00731.x

L. Huiart, F. Eisinger, D. Stoppa-lyonnet, C. Lasset, C. Noguès et al., Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation, Journal of Clinical Epidemiology, vol.55, issue.7, pp.665-675, 2002.
DOI : 10.1016/S0895-4356(02)00401-8

S. Narod, Mutations at the Time of Diagnosis?, Journal of Clinical Oncology, vol.30, issue.1, pp.2-3, 2012.
DOI : 10.1200/JCO.2011.37.6509

K. Im, T. Kirchhoff, X. Wang, T. Green, C. Chow et al., Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers, Human Genetics, vol.38, issue.5, pp.685-699, 2011.
DOI : 10.1007/s00439-011-1003-z

URL : https://hal.archives-ouvertes.fr/hal-00837832

L. Tryggvadottir, H. Sigvaldason, G. Olafsdottir, J. Jonasson, T. Jonsson et al., Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920-2000, JNCI Journal of the National Cancer Institute, vol.98, issue.2, pp.116-122, 2006.
DOI : 10.1093/jnci/djj012

T. Donenberg, J. Lunn, D. Curling, T. Turnquest, E. Krill-jackson et al., A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas, Breast Cancer Research and Treatment, vol.103, issue.3, pp.591-596, 2011.
DOI : 10.1007/s10549-010-1156-9

F. Sandron, La population réunionnaise : Analyse démographique, édition 82 IRD, 2007.
DOI : 10.4000/books.irdeditions.105

. Dubard-gault, Le cancer du sein chez la femme de moins de 50 ans à la Réunion entre, 2005.

. Sancho-garnier, Epidémiologie des cancers gynécologiques, 2013.

I. Cancer-de-l-'ovaire, Disponible sur: http://kach0k, 2008.

S. Chane-kune, Aux origines de l'identité réunionnaise, éditions L'Hamarttan, 1993.

V. Dubut, P. Murail, N. Pech, M. Thionville, and F. Cartault, Inter- and Extra-Indian Admixture and Genetic Diversity in Reunion Island Revealed by Analysis of Mitochondrial DNA, Annals of Human Genetics, vol.70, issue.3, pp.314-334, 2009.
DOI : 10.1111/j.1469-1809.2009.00519.x

URL : https://hal.archives-ouvertes.fr/halshs-00433392

J. Lecarpentier, C. Noguès, E. Mouret-fourme, M. Gauthier-villars, C. Lasset et al., Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO), Breast Cancer Research, vol.70, issue.4, p.99, 2012.
DOI : 10.1158/0008-5472.CAN-09-3460

. Inca, Les cancers en France, 2013.

F. Papin-lefebvre, G. Moutel, N. Duchange, S. De-montgolfier, H. Sancho-garnier et al., Dépistage organisé du cancer du sein en France : pour une optimisation de l'information. Rev DÉpidémiologie Santé Publique, avr, vol.62, issue.2, pp.109-117, 2014.

. Inca, Synthèse activité oncogénétique 2012 et consultations laboratoires 2014, 2014.